09. November 2017

One of the most promising strategies to improve the bioavailability of active pharma- ceutical ingredients is based on the association of the drug with colloidal carriers, for example, polymeric nanoparticles, which are stable in biological environment, protec- tive for encapsulated substances and able to modulate physicochemical characteristics, drug release and biological behaviour.